People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other, Biotechnology, Other Technology, Other Travel, Retailing, Consumer / Retail
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Stance, Inc. | — | Other | Series C | $170.1M | $349.3M | 2009 |
| Allovir, Inc. | — | Biotechnology | Series D+ | $151.3M | $5.0B | 2018 |
| H2scan Corp | — | Other Technology | Series C | $83.2M | $1.4B | 2022 |
| Marker Therapeutics, Inc. | — | Biotechnology | Series B | $29.8M | $93.5M | 2024 |
| Nanolumens, Inc | — | Other Technology | Series A | $20.4M | $69.3M | 2010 |
| Wilson Human Capital Group, Inc. | — | Other | Series A | $13.2M | $49.1M | 2013 |
| McDonald Transit Associates, Inc. | — | Other Travel | Series A | $6.8M | $39.7M | 2009 |
| The People's Movement, Inc. | — | Retailing | Seed | $3.2M | $12.0M | 2013 |
| Fitlife Brands, Inc. | — | Consumer / Retail | Seed | $3.0M | $3.8M | 2009 |
| Marko Technologies Inc. | — | Software / Tech | Seed | $2.5M | $85.2M | 2018 |
| Animas Resources Ltd | — | Other | Pre-Seed | $633K | $3.4M | 2009 |
John Wilson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Wilson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Juan Vera | 2 | 2 |
| Eric Carlborg | 1 | 14 |
| Tod Francis | 1 | 10 |
| Mark Brown | 1 | 10 |
| Joshua Silverman | 1 | 8 |
| Michael Allman | 1 | 8 |
| Pravin Vazirani | 1 | 8 |
| Ansbert Gadicke | 1 | 7 |
| Michael Abrams | 1 | 6 |
| Winnie Wong | 1 | 6 |
| Michael Walkinshaw | 1 | 5 |
| Joel Lanik | 1 | 5 |
| Steven Elms | 1 | 5 |
| JEFF KEARL | 1 | 5 |
| Aaron DeRose | 1 | 4 |
| Gregory E. McKelvey | 1 | 4 |
| Bryan Morris | 1 | 4 |
| Michael S Abrams | 1 | 3 |
| Richard Cope | 1 | 3 |
| David Gatto | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.